학술논문
Targeting Breast Cancer Using 177 Lu-Labeled Trastuzumab and Trastuzumab Fragment: First-in-Human Clinical Experience
Document Type
Article
Author
Source
In: Clinical Nuclear Medicine . (Clinical Nuclear Medicine, 1 June 2024, 49(6):E258-E265)
Subject
Language
English
ISSN
15360229
03639762
03639762